PUBLISHER: The Business Research Company | PRODUCT CODE: 1947033
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947033
Quantitative polymerase chain reaction (qPCR) instruments are specialized laboratory devices used to amplify and simultaneously quantify specific DNA sequences in real time. These instruments track DNA accumulation during each amplification cycle through fluorescent signals, enabling researchers to measure DNA amounts with high sensitivity and precision. They are vital tools in molecular biology, diagnostics, and research for applications including gene expression analysis, pathogen detection, and genetic variation studies.
The main product types of quantitative polymerase chain reaction (qPCR) instruments include quantitative polymerase chain reaction systems, reagents and consumables, and software. Quantitative polymerase chain reaction systems are laboratory instruments designed to amplify and quantify DNA or RNA sequences in real time using fluorescence-based detection. These systems include models such as the 7500, ViiA 7 Dx, Cobas 4800, CFX96, SmartCycler, GeneXpert, Rotor-Gene Q, Rotor-Gene Q 5plex HRM System, BioFire FilmArray systems, and others. They are applied in various fields like gene expression analysis, genotyping, pathogen detection, and diagnostics, and are utilized by end users including diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies, among others.
Tariffs have created challenges for the qPCR instruments market by increasing the cost of importing high-precision instruments and reagents, particularly affecting real-time qPCR systems and digital PCR systems. Regions such as North America, Europe, and Asia-Pacific, which rely heavily on cross-border trade for advanced qPCR technologies, are most impacted. Diagnostic laboratories, hospitals, and biotech companies face higher operational costs and potential delays in instrument procurement. On the positive side, tariffs are encouraging some local manufacturing and assembly initiatives, which could lead to regional supply chain resilience and innovation in cost-effective qPCR solutions.
The quantitative polymerase chain reaction (qpcr) instruments market research report is one of a series of new reports from The Business Research Company that provides quantitative polymerase chain reaction (qpcr) instruments market statistics, including quantitative polymerase chain reaction (qpcr) instruments industry global market size, regional shares, competitors with a quantitative polymerase chain reaction (qpcr) instruments market share, detailed quantitative polymerase chain reaction (qpcr) instruments market segments, market trends and opportunities, and any further data you may need to thrive in the quantitative polymerase chain reaction (qpcr) instruments industry. This quantitative polymerase chain reaction (qpcr) instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The quantitative polymerase chain reaction (qpcr) instruments market size has grown rapidly in recent years. It will grow from $1.66 billion in 2025 to $1.83 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to rising demand for genetic research, increasing prevalence of infectious diseases, advancements in molecular diagnostics, growth of biotech and pharma research, availability of skilled laboratory workforce.
The quantitative polymerase chain reaction (qpcr) instruments market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing adoption of point-of-care diagnostics, expansion of molecular testing in emerging markets, integration of ai and cloud-based analytics, demand for rapid pathogen detection, rising government funding for genomics research. Major trends in the forecast period include high-throughput testing adoption, integration of automation in qpcr workflows, miniaturization of qpcr instruments, demand for multiplexing capabilities, development of point-of-care qpcr solutions.
The rising incidence of infectious diseases is expected to drive the growth of the quantitative polymerase chain reaction (qPCR) instruments market in the future. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The increase in infectious diseases is largely due to the growth in global travel, which accelerates the spread of pathogens across borders. Quantitative polymerase chain reaction (qPCR) instruments assist in combating infectious diseases by providing rapid, sensitive, and precise detection of pathogens, enabling timely diagnosis and effective management of diseases. For example, in February 2024, GOV.UK, a UK government department, reported that tuberculosis (TB) cases in England rose from 4,380 in 2022 to 4,850 in 2023. Hence, the growing incidence of infectious diseases is propelling the expansion of the qPCR instruments market.
Major companies operating in the Quantitative Polymerase Chain Reaction (qPCR) Instruments market are concentrating on creating innovative solutions, such as next-generation real-time qPCR systems that integrate clinical-grade workflows with research adaptability, to address the growing need for faster, higher-throughput molecular diagnostics, enhanced assay sensitivity for personalized medicine and oncology, and improved outbreak preparedness for infectious disease testing. A next-generation qPCR system is a real-time PCR instrument that maintains the fundamental principle of qPCR (simultaneous nucleic acid amplification and fluorescent detection) while incorporating features such as superior thermal uniformity, advanced signal-processing algorithms, user-friendly interfaces, and regulatory-ready IVD workflows. For example, in November 2023, Roche Holding AG, a Switzerland-based diagnostics and biotechnology company, introduced the LightCycler PRO System, a cutting-edge next-generation qPCR platform. The LightCycler PRO System builds on Roche's LightCycler legacy and is designed for both research and IVD applications, offering a new vapor chamber to enhance temperature uniformity across the block, updated software and user interface with improved signal analysis algorithms, and the versatility to run user-developed assays alongside an extensive collection of validated LightMix research and CE-IVD assays.
In April 2023, Thermo Fisher Scientific Inc., a US-based life sciences and clinical research company, formed a partnership with ALPCO-GeneProof to broaden access to PCR diagnostic solutions. Through this collaboration, Thermo Fisher aims to expand its molecular diagnostics portfolio by increasing its CE-IVD assay offerings and strengthening its presence in the European clinical testing market. ALPCO-GeneProof is a US-based diagnostics firm specializing in both molecular and immunodiagnostic solutions.
Major companies operating in the quantitative polymerase chain reaction (qpcr) instruments market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc, Bio Rad Laboratories Inc, QIAGEN N V, Eppendorf SE, Cepheid Inc, Takara Bio Inc, bioMerieux SA, Analytik Jena GmbH, Standard BioTools Inc, Hangzhou Bioer Technology Co Ltd, BioTeke Corporation, GeneReach Biotechnology Corp, Anitoa Systems LLC, Blue Ray Biotech Corp, Chai Biotechnologies, Bio Molecular Systems Pty Ltd, Azure Biosystems Inc
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The quantitative polymerase chain reaction (qPCR) instrument market consists of revenues earned by entities providing services such as analysis software, installation and training, technical support, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantitative polymerase chain reaction (qPCR) instrument market also includes sales of thermal cyclers, optical detection systems, reaction tubes and plates, and analysis software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses quantitative polymerase chain reaction (qpcr) instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for quantitative polymerase chain reaction (qpcr) instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quantitative polymerase chain reaction (qpcr) instruments market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.